Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/12/2003EP1289997A1 Macrolides
03/12/2003EP1289996A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289992A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
03/12/2003EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors
03/12/2003EP1289989A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
03/12/2003EP1289988A1 1,4-diazabicyclo 3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
03/12/2003EP1289987A1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof
03/12/2003EP1289986A1 1,4-diazabicyclo 3.2.2]nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
03/12/2003EP1289985A2 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
03/12/2003EP1289984A1 Novel oxazolidinone derivatives and a process for the preparation thereof
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289982A1 Bioisosteric benzamide derivatives and their use as apob-100 secretion inhibitors
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1289977A2 Triterpenoid derivatives and their use as antiproliferative agents
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
03/12/2003EP1289966A1 SUBSTITUTED LACTAMS AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289963A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289953A1 Serine protease inhibitors
03/12/2003EP1289952A1 Indole derivatives with vascular damaging activity
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289945A1 Aniline disulfide derivatives for treating allergic diseases
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289941A1 Carbamic acid esters as inhibitors of factor xa
03/12/2003EP1289940A2 Excitatory amino acid receptor modulators
03/12/2003EP1289939A1 Phenylglycine derivatives
03/12/2003EP1289936A1 Substituted stilbenes as glucose uptake enhancers
03/12/2003EP1289935A1 Excitatory amino acid receptor modulators
03/12/2003EP1289931A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
03/12/2003EP1289929A1 Shortened synthesis of 3,3-diarylpropylamine derivatives
03/12/2003EP1289928A1 Novel amorphous form of sertraline hydrochloride
03/12/2003EP1289923A2 Epithelial cell cancer drug
03/12/2003EP1289916A2 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
03/12/2003EP1289913A1 Novel antibiotic compounds
03/12/2003EP1289604A2 Compositions containing hexitol and an antiproliferative agent
03/12/2003EP1289576A1 Drug combinations useful for prevention of restenosis
03/12/2003EP1289573A1 A medicinal aerosol formulation
03/12/2003EP1289568A2 Combination product for carrying out a cytotoxic treatment in a mammal
03/12/2003EP1289567A2 Lyophilizable and enhanced compacted nucleic acids
03/12/2003EP1289561A2 Ligand conjugates and methods for preparing same
03/12/2003EP1289560A1 Novel solid dispersion compositions
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289558A2 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
03/12/2003EP1289557A2 Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
03/12/2003EP1289556A2 Phytoestrogenic isoflavone compositions
03/12/2003EP1289540A2 Methods and compositions for producing a neurosalutary effect in a subject
03/12/2003EP1289539A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289538A2 Compositions for enhancing therapeutic effects, containing herbals and/or nutritional supplements and/or minerals and/or vitamins
03/12/2003EP1289533A1 Whitening compositions containing ascomycete derived enzyme
03/12/2003EP1289532A2 Low carbohydrate compositions, kits thereof, and methods of use
03/12/2003EP1289531A2 Kits and methods for optimizing the efficacy of chondroprotective compositions
03/12/2003EP1289530A1 Lipids for modulating immune response
03/12/2003EP1289529A1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
03/12/2003EP1289528A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
03/12/2003EP1289527A2 Use of (+)-alpha -(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
03/12/2003EP1289526A1 Melanocortin receptor agonists
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289524A2 Porous celecoxib matrices and methods of manufacture thereof
03/12/2003EP1289523A1 Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as jnk-inhibitors
03/12/2003EP1289522A2 Medicaments for treating dementia
03/12/2003EP1289521A2 Combination of lipoic acid and c 1 donors for the treatment of disorders of the central nervous system
03/12/2003EP1289520A2 Pharmaceutical compositions for the treatment of depression comprising famotidine
03/12/2003EP1289519A1 Methods of treating androgen deficiency in men using selective antiestrogens
03/12/2003EP1289518A2 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
03/12/2003EP1289517A2 Pharmaceutical compositions comprising cannabidiol derivatives
03/12/2003EP1289516A1 Composition for pain mediation and apparatus and method of use thereof
03/12/2003EP1289515A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof
03/12/2003EP1289514A1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
03/12/2003EP1289513A2 Use of aloe-emodin in the treatment of neuroectodermal tumors
03/12/2003EP1289512A2 Agents and methods for increasing brain chaperonin levels
03/12/2003EP1289511A1 Bactericidal preparation
03/12/2003EP1289510A2 Compositions, kits, and methods for promoting defined health benefits
03/12/2003EP1289509A2 Compositions containing naphthaquinone and an antiproliferative agent
03/12/2003EP1289508A2 Method for the prevention of apoptosis
03/12/2003EP1289507A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
03/12/2003EP1289506A1 Novel composition
03/12/2003EP1289505A1 Novel process
03/12/2003EP1289504A2 Neurotoxin implant
03/12/2003EP1289503A2 O/w emulsion
03/12/2003EP1289500A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1289499A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289498A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1289497A1 Novel aqueous anti-inflammatory pharmaceutical formulation
03/12/2003EP1289496A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
03/12/2003EP1289495A1 Process for the preparation of a sterile ointment containing acyclovir
03/12/2003EP1289493A1 Pharmaceutical compositions comprising desglymidodrine as an active drug substance
03/12/2003EP1289491A1 Cosmetic and/or dermatological composition based on cocoa extracts
03/12/2003EP1289489A2 Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-d-glucopyranoside
03/12/2003EP1289384A2 Aqueous chondroprotective compositions having defined ph limitations for efficacious delivery
1 ... 5538 5539 5540 5541 5542 5543 5544 5545 5546 5547 5548 5549 5550 5551 5552 5553 5554 5555 5556 5557 5558 ... 7860